Suven Life Sciences share news, announcements and annual reports
NSE: SUVENBSE: 530239Healthcare ServicesSmall Cap
Share price at the NSE close on 29 Oct 2026. Previous close ₹268.05.
29 Oct: open ₹269.90, high ₹269.90, low ₹261.80
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹7,465 Cr806th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- Lossover the last 12 months
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- Shares changed
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- −100.5%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- −63.0%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.00
- Volume, NSEVolume. Shares traded on the last trading day. Volume in the glossary
- 2,90,103
Suven Life Sciences has 802 announcements on record, routine notices left out; none in the 30 days to 29 Oct 2026, the latest on 3 Sep 2026.
Last results date
The last board meeting held for results; the company has not yet given notice of the next.Suven Life Sciences quarterly results
The board met on 6 Aug 2026 to consider financial results
Notice filed 30 Jul 2026
To consider and approve the financial results for the period ended Jun 30, 2026
Suven Life Sciences annual reports, presentations and earnings calls
The company's own documents, latest first.Suven Life Sciences financials, year by year
Annual reports17
- Annual report, year to Mar 202630 Jul 2026
- Annual report, year to Mar 202530 Jul 2025
- Annual report, year to Mar 20244 Jul 2024
- Annual report, year to Mar 202311 Jul 2023, a zip file
- Annual report, year to Mar 202211 Jul 2022, a zip file
12 earlier reports
- Annual report, year to Mar 202112 Jul 2021, a zip file
- Annual report, year to Mar 202017 Sep 2020, a zip file
- Annual report, year to Mar 201920 Jul 2019, a zip file
- Annual report, year to Mar 201820 Aug 2018, a zip file
- Annual report, year to Mar 201717 Aug 2017, a zip file
- Annual report, year to Mar 201626 Aug 2016, a zip file
- Annual report, year to Mar 201521 Jul 2015, a zip file
- Annual report, year to Mar 201418 Jul 2014, a zip file
- Annual report, year to Mar 201318 Jul 2013, a zip file
- Annual report, year to Mar 201217 Sep 2012, a zip file
- Annual report, year to Mar 201121 Jun 2012, a zip file
- Annual report, year to Mar 201025 Aug 2010, a zip file
Investor presentations17
- Investor Presentation14 Nov 2019
- Investor Presentation14 Aug 2019
- Investor Presentation25 May 2019
- Investor Presentation (Corrected)5 Feb 2019
- Investor Presentation5 Feb 2019
12 earlier presentations
- Investor Presentation14 Nov 2018
- Investor Presentation14 Aug 2018, a zip file
- Investor Presentation15 May 2018, a zip file
- Investor Presentation30 Jan 2018, a zip file
- Investor Presentation11 Nov 2017, a zip file
- Investor Presentation14 Aug 2017, a zip file
- Analysts/Institutional Investor Meet/Con. Call Updates - Annual Investors Conference on 05th June, 2017 (Revised)With reference to above and further to our letter dated 01st June, 2017. We have noticed an error in our recently submitted corporate presentation to be given on 05th June, 2017 at the Annual Investor Conference Trinity India 2017 organized by B&K Securities in Mumbai. Hence we are re-submitting the corrected corporate presentation with updated information about our company for the information of investors/analysts.Please find enclosed Corporate Presentation.3 Jun 2017, a zip file
- Investor Presentation13 May 2017, a zip file
- Investor Presentation1 Feb 2017, a zip file
- Corporate Presentation.31 May 2016, a zip file
- Corporate Presentation.14 Dec 2015, a zip file
- Presentation on communication to investor September 2015.10 Nov 2015, a zip file
Suven Life Sciences merger and demerger filings
Filings about a merger, demerger or scheme of arrangement, latest first.
Filings1
- Scheme of Arrangement7 Jan 2020
Suven Life Sciences share news and announcements
Newest first. Page 1 of 17.
Sep 2026
Aug 2026
11 Aug · Business
6 Aug · Results
Jul 2026
30 Jul · Board meeting
30 Jul · General Updates
30 Jul · General Updates
30 Jul · Meeting
14 Jul · Analysts
8 Jul · Board meeting
Jun 2026
May 2026
29 May · General Updates
19 May · Legal
The exchange asked on 18 May 2026
14 May · Business
13 May · Results
13 May · Disclosure
6 May · Board meeting
Board Meeting to be held on 13-May-2026 to inter-alia consider and approve the Audited Financial results of the Company for the Yearly ended March 2026 .
Apr 2026
8 Apr · Legal
The exchange asked on 7 Apr 2026
Mar 2026
Feb 2026
6 Feb · Legal
The exchange asked on 5 Feb 2026
3 Feb · Business
Jan 2026
29 Jan · Results
22 Jan · Board meeting
Dec 2025
Nov 2025
12 Nov · Business
11 Nov · Results
Aug 2025
22 Aug · Meeting
13 Aug · Business
13 Aug · Results
5 Aug · Board meeting
Jul 2025
30 Jul · Updates
30 Jul · Meeting
24 Jul · Disclosure
How the price met the news
The latest 30. The first session after each announcement, beside the market.
That dayThe first session's move. The first session's close after the announcement against the close before it, as a per cent change, on prices adjusted for splits and bonuses.Against the Nifty 500Against the Nifty 500. The share's move less the Nifty 500's move the same session, in percentage points (pts).Market median on that newsThe market's median move on that news. The middle first-session move of every listed company that filed the same kind of announcement, half moving more and half less.Five sessionsFive sessions' move. The close five sessions after the announcement against the close before it, as a per cent change.Five sessions against the Nifty 500Five sessions against the Nifty 500. The share's five-session move less the Nifty 500's move over the same five sessions, in percentage points (pts).Volume, times usualVolume, times usual. The session's shares traded divided by the average of the twenty sessions before it.Delivery against usualDelivery against usual. The share of the session's volume delivered into demat accounts, rather than bought and sold again the same day, less its average over the twenty sessions before, in percentage points (pts). Delivery against usual in the glossary
- 6 Aug 2026Resultsdown 2.68%−2.7 pts vs Nifty 500market median −0.7% · five sessions +1.2% (+1.5 pts vs Nifty 500) · volume 0.8× usual · delivery −3.1 pts against usual · The announcement
- 13 May 2026Resultsdown 3.05%−3.4 pts vs Nifty 500market median −0.7% · five sessions +24.5% (+23.5 pts vs Nifty 500) · volume 1.0× usual · delivery −4.7 pts against usual · The announcement
- 29 Jan 2026Resultsdown 0.56%−0.8 pts vs Nifty 500market median −0.7% · five sessions +12.6% (+11.0 pts vs Nifty 500) · volume 0.7× usual · delivery −8.8 pts against usual · The announcement
- 11 Nov 2025Resultsdown 2.62%−3.0 pts vs Nifty 500market median −0.7% · five sessions −3.3% (−4.8 pts vs Nifty 500) · volume 1.0× usual · delivery −2.4 pts against usual · The announcement
- 13 Aug 2025Resultsdown 0.41%−1.0 pts vs Nifty 500market median −0.7% · five sessions +0.7% (−1.9 pts vs Nifty 500) · volume 1.6× usual · The announcement
- 13 May 2025Resultsup 11.93%+12.6 pts vs Nifty 500market median −0.7% · five sessions +35.9% (+34.3 pts vs Nifty 500) · volume 19.7× usual · delivery −25.4 pts against usual · The announcement
- 30 Jan 2024Resultsup 6.78%+7.5 pts vs Nifty 500market median −0.7% · five sessions +3.2% (+2.5 pts vs Nifty 500) · volume 0.7× usual · delivery −18.8 pts against usual · The announcement
- 26 Jul 2022Resultsdown 1.84%−0.9 pts vs Nifty 500market median −0.7% · five sessions +3.1% (−0.9 pts vs Nifty 500) · volume 1.0× usual · delivery −5.7 pts against usual · The announcement
- 9 May 2022Resultsdown 3.04%−1.9 pts vs Nifty 500market median −0.7% · five sessions −3.0% (+1.8 pts vs Nifty 500) · volume 0.5× usual · delivery −12.4 pts against usual · The announcement
- 27 Jan 2021Board or managers changeddown 4.65%−3.0 pts vs Nifty 500market median 0.0% · five sessions +2.1% (−0.5 pts vs Nifty 500) · volume 0.6× usual · delivery +4.1 pts against usual · The announcement
20 earlier announcements
- 23 Apr 2020Credit ratingup 4.93%+3.7 pts vs Nifty 500market median 0.0% · five sessions +27.1% (+23.6 pts vs Nifty 500) · volume 0.1× usual · delivery +9.0 pts against usual · The announcement
- 17 Oct 2019Credit ratingup 1.83%+0.7 pts vs Nifty 500market median 0.0% · five sessions +13.0% (+11.4 pts vs Nifty 500) · volume 1.0× usual · delivery +3.2 pts against usual · The announcement
- 6 Feb 2019Dividendup 7.05%+6.1 pts vs Nifty 500market median 0.0% · five sessions +15.7% (+16.9 pts vs Nifty 500) · volume 3.9× usual · delivery −11.4 pts against usual · The announcement
- 1 Oct 2018Credit ratingup 0.19%−0.4 pts vs Nifty 500market median 0.0% · five sessions −9.5% (−3.9 pts vs Nifty 500) · volume 0.6× usual · delivery −3.7 pts against usual · The announcement
- 30 Jan 2018Dividenddown 6.46%−5.7 pts vs Nifty 500market median 0.0% · five sessions −16.9% (−12.0 pts vs Nifty 500) · volume 3.5× usual · delivery −25.3 pts against usual · The announcement
- 1 Feb 2017Dividenddown 1.11%−3.0 pts vs Nifty 500market median 0.0% · five sessions +6.2% (+3.2 pts vs Nifty 500) · volume 1.2× usual · delivery −7.5 pts against usual · The announcement
- 8 Mar 2016Dividendup 1.30%+1.2 pts vs Nifty 500market median 0.0% · five sessions +4.0% (+3.3 pts vs Nifty 500) · volume 1.0× usual · delivery −17.6 pts against usual · The announcement
- 26 May 2015Dividenddown 4.50%−4.2 pts vs Nifty 500market median 0.0% · five sessions −8.4% (−9.1 pts vs Nifty 500) · volume 3.7× usual
- 10 Feb 2015Resultsdown 3.08%−3.6 pts vs Nifty 500market median −0.7% · five sessions +4.2% (+0.6 pts vs Nifty 500) · volume 1.2× usual
- 22 May 2014Dividenddown 0.95%−1.8 pts vs Nifty 500market median 0.0% · five sessions −7.8% (−8.9 pts vs Nifty 500) · volume 7.3× usual
- 14 May 2013Dividenddown 4.75%−5.0 pts vs Nifty 500market median 0.0% · five sessions −9.5% (−12.3 pts vs Nifty 500) · volume 2.2× usual
- 22 Jan 2013Board or managers changeddown 1.78%−1.1 pts vs Nifty 500market median 0.0% · five sessions −4.6% (−3.9 pts vs Nifty 500) · volume 0.9× usual
- 16 Aug 2012Dividendup 1.92%+2.2 pts vs Nifty 500market median 0.0% · five sessions +17.8% (+17.5 pts vs Nifty 500) · volume 5.9× usual
- 1 Feb 2012Resultsdown 0.63%−1.5 pts vs Nifty 500market median −0.7% · five sessions +2.8% (0.0 pts vs Nifty 500) · volume 2.2× usual
- 1 Jun 2011Dividendup 5.06%+4.5 pts vs Nifty 500market median 0.0% · five sessions +2.5% (+2.6 pts vs Nifty 500) · volume 1.2× usual
- 3 May 2010Dividenddown 4.63%−4.0 pts vs Nifty 500market median 0.0% · five sessions −10.6% (−6.3 pts vs Nifty 500) · volume 1.1× usual
- 30 Apr 2010Dividendup 5.02%+4.3 pts vs Nifty 500market median 0.0% · five sessions −2.7% (−0.8 pts vs Nifty 500) · volume 1.5× usual
- 29 Jul 2009Dividenddown 3.85%−2.8 pts vs Nifty 500market median 0.0% · five sessions −6.0% (−8.1 pts vs Nifty 500) · volume 2.4× usual
- 15 Jan 2009Board or managers changeddown 1.05%+2.0 pts vs Nifty 500market median 0.0% · five sessions −4.9% (−0.8 pts vs Nifty 500) · volume 0.6× usual
- 25 Jul 2008Dividendup 0.38%+2.4 pts vs Nifty 500market median 0.0% · five sessions +1.5% (+3.5 pts vs Nifty 500) · volume 1.3× usual
Suven Life Sciences results filing dates and deadlines
Listed companies must file quarterly results within 45 days, and the year's within 60.
Days to fileDays to file. The days from the period's end to the day the results reached the exchange.DeadlineDeadline, days. The days the rules allow from the period's end: 45 for a quarter or half year, and 60 for the year and the March quarter filed with it. A company that listed after the period ended has until 21 days after its listing where that is later.